Insights into Telomerase/hTERT Alternative Splicing Regulation Using Bioinformatics and Network Analysis in Cancer
The reactivation of telomerase in cancer cells remains incompletely understood. The catalytic component of telomerase, <i>hTERT</i>, is thought to be the limiting component in cancer cells for the formation of active enzymes. <i>hTERT</i> gene expression is regulated at sever...
Main Authors: | Andrew T. Ludlow, Aaron L. Slusher, Mohammed E. Sayed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/5/666 |
Similar Items
-
The Role of Alternative RNA Splicing in the Regulation of <i>hTERT</i>, Telomerase, and Telomeres: Implications for Cancer Therapeutics
by: Aaron L. Slusher, et al.
Published: (2020-06-01) -
The hTERTα Splice Variant is a Dominant Negative Inhibitor of Telomerase Activity
by: Lorel M. Colgin, et al.
Published: (2000-09-01) -
Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes
by: Anna A. Plyasova, et al.
Published: (2021-05-01) -
Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity
by: Xuewen Liu, et al.
Published: (2017-03-01) -
Expression Profile of a γ-Deletion Variant of the Human Telomerase Reverse Transcriptase Gene
by: Hisashi Hisatomi, et al.
Published: (2003-05-01)